Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 60 resultados

PRONACORE: Glycan-coated Protein(oid) Nanocarriers for the Delivery and Controlled Release of Anticancer Agent... HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT tramitó un HORIZON EUROPE: HORIZON-WIDERA-2022-TALENTS-04 Cancer is a leading cause of death in the EU and worldwide. Chemotherapy has high risks and severe side effects due to the poor bioavailabil...
2023-11-15 - 2026-03-31 | Financiado

ELIXIR-STEERS: ELIXIR STEERS HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un HORIZON EUROPE: HORIZON-INFRA-2023-DEV-01 ELIXIR unites Europe’s leading life science organisations in managing and safeguarding the increasing volume of data being generated by publ...
2023-11-03 - 2027-01-31 | Financiado

NeuroblastORG: Developing neural crest organoids with inducible neuroblastoma to model chemoresistance in MYCN ampl... HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT tramitó un HORIZON EUROPE: HORIZON-WIDERA-2022-TALENTS-02 Neuroblastoma (NB) is the most common cancer in infants and the 3rd most common cancer in children. According to the WHO 90% of NBs occur in...
2022-09-26 - 2025-02-28 | Financiado

RNA-top: RNA topology of test samples and single extracellular vesicles: how cells package RNA messages to co... HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 In RNA-top, I will investigate the precise location(s) and quantity of RNA associated with extracellular vesicles (e.g. EV-RNA topology). To...
2022-06-27 - 2025-07-31 | Financiado

HYPERSTIM: High-dimensional electrical stimulation for visual prosthesis HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 Future advanced neuroprostheses will need to transfer orders of magnitude more information to the brain than currently possible. This is mos...
2022-05-30 - 2026-10-31 | Financiado

ALLODD: Allostery in Drug Discovery HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-MSCA-ITN-2020 Most current drugs are designed to bind directly to the primary active sites (also known as orthosteric sites) of their biological targets....
2021-05-28 - 2025-08-31 | Financiado

SAFEMILK: Innovative technology for milk safety HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-MSCA-RISE-2020 The proposal is focused on the development of novel complex assay for evaluation of milk safety, which is important for dairy industry to as...
2020-10-22 - 2025-04-30 | Financiado

ELIXIR-CONVERGE: Connect and align ELIXIR Nodes to deliver sustainable FAIR life science data management services HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-INFRADEV-2018-2020 The diversity, complexity and volume, as well as privacy and regulatory considerations, necessitate a collaborative and federated approach t...
2020-02-06 - 2023-07-31 | Financiado

CompBat: Computer aided desing for next generation flow batteries HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-LC-BAT-2019-2020 CompBat will focus on developing tools for discovery of new prospective candidates for next generation flow batteries, based on machine lear...
2019-10-31 - 2023-05-31 | Financiado

EU-OPENSCREEN-DRIVE: Ensuring long term sustainability of excellence in chemical biology within Europe and beyond HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-INFRADEV-2018-2020 EU-OPENSCREEN (EU-OS), the European Research Infrastructure of Open Screening Platforms for Chemical Biology, builds a distributed organizat...
2018-12-13 - 2023-10-31 | Financiado

Neo-PRISM-C: Neo PRISM C NEurodevelopmental Optimal Predictors Risk factors and Intervention from a Systems ap... HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-MSCA-ITN-2018 Mental health disorders pose a massive economic and societal burden. Emerging early in development and resulting in long-term disability, ne...
2018-08-30 - 2023-08-31 | Financiado

POSITION-II: A pilot line for the next generation of smart catheters and implants HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-ECSEL-2017-1-IA-two-stage The objective of POSITION-II is to bring innovation in the development and production of smart catheters by the introduction of open technol...
2018-05-17 - 2021-09-30 | Financiado

FlowCamp: European Training Network to improve materials for high performance low cost next generation redox... HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-MSCA-ITN-2017 Renewable energy sources like wind turbines require large-scale, stationary energy storage systems to balance out fluctuations in energy gen...
2017-08-10 - 2022-02-28 | Financiado

HyLAW: Identification of legal rules and administrative processes applicable to Fuel Cell and Hydrogen tech... HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-JTI-FCH-2016-1 The fuel cells and hydrogen (FCH) industry has made considerable progress toward market deployment. However existing legal framework and adm...
2016-12-14 - 2019-03-31 | Financiado

FORMILK: Innovative technology for the detection of enzyme activity in milk HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-MSCA-RISE-2015 The proposal is focused on the development of novel methods of detection of activity of enzymes, such as plasmin and lactase, important for...
2015-12-10 - 2019-12-31 | Financiado

FRAGNET: FRAGments training NETwork HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT participó en un H2020: H2020-MSCA-ITN-2015 The promise of more efficient lead discovery is fuelling the enthusiasm for fragment-based lead discovery (FBLD). In this approach, highly s...
2015-08-11 - 2020-02-29 | Financiado

BARREL: Barrel Assemblies of Membrane Active Artificial Foldamers HUNREN TERMESZETTUDOMANYI KUTATOKOZPONT tramitó un H2020: H2020-MSCA-IF-2014 Development of resistance by bacteria to antibiotics makes design of novel antimicrobial compounds increasingly important. As persistent cel...
2015-03-25 - 2017-07-31 | Financiado

HUN-REN RESEARCH CENTRE FOR NATURAL SCIE...